Home » Topics » Regulatory

Regulatory
RSS

New Videx capsule formulation approved in France

Feb. 25, 2000

Remicade recommended for approval in E.U. for treatment of rheumatoid arthritis

Feb. 24, 2000

Nastech's NDA for intranasal scopolamine not accepted for filing

Feb. 24, 2000

Pregabalin now claimed for renal colic-associated pain

Feb. 24, 2000

New antiepileptic Diastat available in Canada for ARS

Feb. 23, 2000

GABA analogues useful for insomnia

Feb. 22, 2000

Small patient study indicates potential of baclofen in treating alcoholism

Feb. 22, 2000

FDA approves first vaccine for prevention of invasive pneumococcal disease in infants and toddlers

Feb. 18, 2000

Pharmacyclics' texaphyrins now claimed for use in macrophage-mediated conditions

Feb. 17, 2000

Transmucosal clemastine under study at Nastech for motion sickness

Feb. 16, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...